MIDAZOLAM INJECTION
MIDAZOLAM INJECTION
Approved
DIN Number
02242905
Drug Class
Human
Market Date
Mar 26, 2001
Company
HC
fresenius kabi canada ltd
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02242905
AIG Number0119935001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05CD08 MIDAZOLAM
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
,
Intramuscular
AHFS Classification28:24.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
MIDAZOLAMActive
Strength: 5 MG / ML
Monograph: MIDAZOLAM